Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP610826.RAFqXKci1d7lXRUryLxfaonlaJn2A4dD4DZmXRbyihFhk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP610826.RAFqXKci1d7lXRUryLxfaonlaJn2A4dD4DZmXRbyihFhk130_assertion type Assertion NP610826.RAFqXKci1d7lXRUryLxfaonlaJn2A4dD4DZmXRbyihFhk130_head.
- NP610826.RAFqXKci1d7lXRUryLxfaonlaJn2A4dD4DZmXRbyihFhk130_assertion description "[Present and earlier data on 23 PAs showed that tumors with the highest frequency of abnormal karyotypes revealed by cytogenetics and/or interphase FISH were PRL (78%), followed by NFPA (26%) and GH (18%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610826.RAFqXKci1d7lXRUryLxfaonlaJn2A4dD4DZmXRbyihFhk130_provenance.
- NP610826.RAFqXKci1d7lXRUryLxfaonlaJn2A4dD4DZmXRbyihFhk130_assertion evidence source_evidence_literature NP610826.RAFqXKci1d7lXRUryLxfaonlaJn2A4dD4DZmXRbyihFhk130_provenance.
- NP610826.RAFqXKci1d7lXRUryLxfaonlaJn2A4dD4DZmXRbyihFhk130_assertion SIO_000772 10760821 NP610826.RAFqXKci1d7lXRUryLxfaonlaJn2A4dD4DZmXRbyihFhk130_provenance.
- NP610826.RAFqXKci1d7lXRUryLxfaonlaJn2A4dD4DZmXRbyihFhk130_assertion wasDerivedFrom befree-20150227 NP610826.RAFqXKci1d7lXRUryLxfaonlaJn2A4dD4DZmXRbyihFhk130_provenance.
- NP610826.RAFqXKci1d7lXRUryLxfaonlaJn2A4dD4DZmXRbyihFhk130_assertion wasGeneratedBy ECO_0000203 NP610826.RAFqXKci1d7lXRUryLxfaonlaJn2A4dD4DZmXRbyihFhk130_provenance.